CFO
OPK icon

CVA Family Office’s Opko Health OPK Stock Holding History

CVA Family Office’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1
Closed – – 970
2021
Q1 		$0 Buy
+1
New +$5 ﹤0.01% 785

Other funds holding OPK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

CVA Family Office's OPK Position: Q2 2021 in Review

CVA Family Office sold out of Opko Health (OPK) in Q2 2021, closing a stake of 1 share.

CVA Family Office first reported a position in OPK in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 233 funds tracked by Wall St. Rank hold OPK as of Q2 2021.

  • CVA Family Office reported no remaining Opko Health position as of Q2 2021 after selling out during the quarter.
  • CVA Family Office sold 1 Opko Health share in Q2 2021.
  • CVA Family Office first reported a position in Opko Health in Q1 2021 and held it in 1 quarter.
  • CVA Family Office's Opko Health position peaked at $0 in Q1 2021.
  • 233 funds tracked by Wall St. Rank held Opko Health as of Q2 2021.

Based on CVA Family Office's 13F filing for Q2 2021, filed 13 Jul 2021.